• OPEN AN ACCOUNT
Indian Indices
Nifty
24,750.70 -82.90
(-0.33%)
Sensex
81,451.01 -182.01
( -0.22%)
Bank Nifty
55,749.70 203.65
( 0.37%)
Nifty IT
37,321.75 -432.40
( -1.15%)
Global Indices
Nasdaq
42,240.69 120.99
(0.29%)
Dow Jones
5,933.08 23.53
(0.40%)
Hang Seng
38,097.61 -335.37
(-0.87%)
Nikkei 225
8,716.45 -9.56
(-0.11%)
Forex
USD-INR
85.43 0.12
(0.15%)
EUR-INR
96.59 -0.28
(-0.29%)
GBP-INR
115.15 -0.33
(-0.28%)
JPY-INR
0.59 0.00
(-0.46%)

EQUITY - MARKET SCREENER

HDFC Life Insurance Company Ltd
Industry :  Finance & Investments
BSE Code
ISIN Demat
Book Value()
540777
INE795G01014
74.8808716
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
HDFCLIFE
93.46
168474.51
EPS(TTM)
Face Value()
Div & Yield %
8.37
10
0.27
 

swadha nature ltd
Transgene Biotek Ltd - Board Meeting Outcome for Outcome Of Board Meeting And Submission Of Audited Financial Results For The Fourth Quarter And Financial Year Ended March 31 2025
May 07,2025
This has reference to our letter dated April 26 2025 The Board of Directors of the Company at their meeting held on May 07 2025 have resolved as follows: Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we enclose herewith the following: a) Audited Financial Results (Standalone and Consolidated) of the Company for the fourth quarter and financial year ended March 31 2025. b) Report of the Auditors on the Audited Financial Results both for Standalone and Consolidated financial statements for the financial year ended March 31 2025. c) Declaration pursuant to Regulation 33(3)(d) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 for Consolidated and Standalone Financial Statements for the Financial Year ended March 31 2025. The meeting of the Board of Directors of the Company commenced at 11.00 AM and concluded at 03.30 PM.